Related Experiment Video
Updated: Mar 9, 2026

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
Published on: November 10, 2016
ERCC2/XPD Lys751Gln alter DNA repair efficiency of platinum-induced DNA damage through P53 pathway
Guopei Zhang1, Yangyang Guan1, Yuejiao Zhao2
1Dept. of Toxicology, School of Public Health, China Medical University, Shenyang, PR China.
Abstract:
Platinum-based treatment causes Pt-DNA adducts which lead to cell death. The platinum-induced DNA damage is recognized and repaired by the nucleotide excision repair (NER) system of which ERCC2/XPD is a critical enzyme. Single nucleotide polymorphisms in ERCC2/XPD have been found to be associated with platinum resistance. The aim of the present study was to investigate whether ERCC2/XPD Lys751Gln (rs13181) polymorphism is causally related to DNA repair capacity of platinum-induced DNA damage. First, cDNA clones expressing different genotypes of the polymorphism was transfected to an ERCC2/XPD defective CHO cell line (UV5). Second, all cells were treated with cisplatin. Cellular survival rate were investigated by MTT growth inhibition assay, DNA damage levels were investigated by comet assay and RAD51 staining. The distribution of cell cycle and the change of apoptosis rates were detected by a flow cytometric method (FCM). Finally, P53mRNA and phospho-P53 protein levels were further investigated in order to explore a possible explanation. As expected, there was a significantly increased in viability of UV5ERCC2 (AA) as compared to UV5ERCC2 (CC) after cisplatin treatment. The DNA damage level of UV5ERCC2 (AA) was significant decreased compared to UV5ERCC2 (CC) at 24 h of treatment. Mutation of ERCC2rs13181 AA to CC causes a prolonged S phase in cell cycle. UV5ERCC2 (AA) alleviated the apoptosis compared to UV5ERCC2 (CC), meanwhile P53mRNA levels in UVERCC2 (AA) was also lower when compared UV5ERCC2 (CC). It co-incides with a prolonged high expression of phospho-P53, which is relevant for cell cycle regulation, apoptosis, and the DNA damage response (DDR). We concluded that ERCC2/XPD rs13181 polymorphism is possibly related to the DNA repair capacity of platinum-induced DNA damage. This functional study provides some clues to clarify the relationship between cisplatin resistance and ERCC2/XPDrs13181 polymorphism.
Insights
The ERCC2/XPD Lys751Gln (rs13181) polymorphism affects DNA repair capacity. The AA genotype shows increased viability and reduced DNA damage after cisplatin treatment compared to the CC genotype, suggesting a role in platinum resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Platinum-based chemotherapy induces DNA damage, primarily Pt-DNA adducts, leading to cancer cell death.
- The Nucleotide Excision Repair (NER) system, involving ERCC2/XPD, repairs platinum-induced DNA damage.
- Single Nucleotide Polymorphisms (SNPs) in ERCC2/XPD are linked to platinum resistance.
Purpose of the Study:
- To investigate the causal relationship between the ERCC2/XPD Lys751Gln (rs13181) polymorphism and DNA repair capacity for platinum-induced DNA damage.
- To elucidate the functional impact of different ERCC2/XPD rs13181 genotypes on cellular response to cisplatin.
Main Methods:
- Transfection of ERCC2/XPD deficient CHO cells (UV5) with cDNA clones expressing different rs13181 genotypes (AA and CC).
- Treatment of transfected cells with cisplatin.
- Assessment of cellular viability (MTT assay), DNA damage (comet assay, RAD51 staining), cell cycle distribution, apoptosis rates (FCM), and P53 mRNA/protein levels.
Main Results:
- UV5 cells expressing ERCC2 (AA) genotype exhibited significantly higher viability and reduced DNA damage levels compared to UV5 cells expressing ERCC2 (CC) genotype after cisplatin treatment.
- The ERCC2 rs13181 AA to CC genotype mutation was associated with prolonged S phase in the cell cycle.
- Apoptosis was alleviated in UV5ERCC2 (AA) cells, correlating with lower P53 mRNA levels and prolonged phospho-P53 expression.
Conclusions:
- The ERCC2/XPD rs13181 polymorphism is functionally linked to DNA repair capacity of platinum-induced DNA damage.
- This polymorphism may influence cisplatin resistance by modulating DNA repair efficiency, cell cycle progression, and apoptosis.
- Findings provide insights into the relationship between cisplatin resistance and ERCC2/XPD rs13181 polymorphism.
Related Concept Videos
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Base Excision Repair
The first step of...
Base Excision Repair
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle

